{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:59:14Z","timestamp":1772121554206,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["cell.com","bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Parasitology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.pt.2014.07.001","type":"journal-article","created":{"date-parts":[[2014,8,25]],"date-time":"2014-08-25T11:46:46Z","timestamp":1408967206000},"page":"423-425","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The advent of ivermectin: people, partnerships, and principles"],"prefix":"10.1016","volume":"30","author":[{"given":"Andy","family":"Crump","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pt.2014.07.001_bib0005","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.pt.2005.08.014","article-title":"Ivermectin 20 years on: maturation of a wonder drug","volume":"21","author":"Geary","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2014.07.001_bib0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pt.2005.01.005","article-title":"Satoshi \u014cmura: in pursuit of nature's bounty","volume":"21","author":"Crump","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.pt.2014.07.001_bib0015","doi-asserted-by":"crossref","first-page":"10715","DOI":"10.1073\/pnas.0403390101","article-title":"Inhibition of fatty acid synthase (FAS) suppresses HER2\/neu (erbB-2) oncogene overexpression in cancer cells","volume":"101","author":"Menendez","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2014.07.001_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ja.2008.4","article-title":"Chemical biology of natural indolocarbazole products: 30 years since the discovery of staurosporine","volume":"62","author":"Nakano","year":"2009","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.pt.2014.07.001_bib0025","article-title":"Multiauthor papers: onward and upward","author":"King","year":"2012","journal-title":"ScienceWatch Newsletter"},{"key":"10.1016\/j.pt.2014.07.001_bib0030","series-title":"The Moral Corporation","author":"Vagelos","year":"2006"},{"key":"10.1016\/j.pt.2014.07.001_bib0060","series-title":"Medicine, Science and Merck","author":"Vagelos","year":"2004"},{"key":"10.1016\/j.pt.2014.07.001_bib0035","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.1073\/pnas.80.14.4572","article-title":"Research and Innovation","volume":"80","author":"Sarrett","year":"1983","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.pt.2014.07.001_bib0040","first-page":"352","article-title":"Max Tishler","volume":"Vol. 66","author":"Sarrett","year":"1995"},{"key":"10.1016\/j.pt.2014.07.001_bib0065","series-title":"Ivermectin and Abamectin","year":"1989"},{"key":"10.1016\/j.pt.2014.07.001_bib0045","series-title":"Inventive Minds: Creativity in Technology","first-page":"194","article-title":"The genesis of the antiparasitic drug, ivermectin","author":"Campbell","year":"1992"},{"key":"10.1016\/j.pt.2014.07.001_bib0050","series-title":"Trends in Antibiotic Research: Genetics, Biosyntheses, Actions and New Substances","first-page":"154","article-title":"Avermectins, antiparasitic lactones produced by Streptomyces avermitilis isolated from a soil in Japan","author":"Stapley","year":"1982"},{"key":"10.1016\/j.pt.2014.07.001_bib0055","series-title":"Sustaining the Drive to Overcome the Global Impact of Neglected Tropical Diseases (2nd WHO Report on Neglected Tropical Diseases)","author":"WHO","year":"2013"}],"container-title":["Trends in Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492214001111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471492214001111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:26:12Z","timestamp":1538285172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471492214001111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S1471492214001111"],"URL":"https:\/\/doi.org\/10.1016\/j.pt.2014.07.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718555711.793499574","asserted-by":"object"}]},"ISSN":["1471-4922"],"issn-type":[{"value":"1471-4922","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The advent of ivermectin: people, partnerships, and principles","name":"articletitle","label":"Article Title"},{"value":"Trends in Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pt.2014.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}